News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
370,271 Results
Type
Article (11229)
Company Profile (47)
Press Release (358995)
Section
Business (123504)
Career Advice (393)
Deals (21515)
Drug Delivery (29)
Drug Development (43288)
Employer Resources (33)
FDA (8541)
Job Trends (10458)
News (198014)
Policy (17040)
Tag
Academia (1658)
Africa (277)
Allergies (34)
Alliances (20985)
Alzheimer's disease (641)
Approvals (8511)
Arizona (69)
Artificial intelligence (34)
Asia (22638)
Australia (2913)
Bankruptcy (138)
Best Places to Work (9142)
Biotechnology (41)
Breast cancer (34)
C2C Services and Suppliers (34979)
California (1153)
Canada (512)
Cancer (311)
Career advice (322)
Cell therapy (62)
China (122)
Clinical research (34882)
Collaboration (83)
Colorado (53)
Connecticut (47)
COVID-19 (1126)
Cystic fibrosis (39)
Data (225)
Diabetes (43)
Diagnostics (4093)
Earnings (67781)
Europe (43341)
Events (71533)
Executive appointments (83)
FDA (8686)
Florida (183)
Funding (88)
Gene therapy (39)
GLP-1 (212)
Government (2484)
Healthcare (14921)
Hotbed/Location (271123)
Idaho (36)
Illinois (159)
Indiana (121)
Infectious disease (1132)
Inflammatory bowel disease (64)
Interviews (59)
IPO (12383)
Job creations (1404)
Job search strategy (291)
Kansas (56)
Layoffs (168)
Legal (3484)
Lung cancer (81)
Maine (43)
Manufacturing (44)
Maryland (326)
Massachusetts (1003)
Medical device (9392)
Medtech (9393)
Mergers & acquisitions (9118)
Metabolic disorders (103)
Michigan (83)
Minnesota (153)
Neuroscience (718)
New Hampshire (41)
New Jersey (408)
New York (376)
NextGen Class of 2024 (5208)
Non-profit (4191)
North Carolina (413)
Northern California (518)
Obesity (64)
Ohio (74)
Opinion (56)
Pennsylvania (350)
People (26233)
Phase I (10268)
Phase II (15315)
Phase III (12506)
Pipeline (103)
Postmarket research (1176)
Preclinical (3450)
Press Release (61)
Radiopharmaceuticals (142)
Rare diseases (68)
Real estate (2734)
Regulatory (11581)
Research institute (1474)
Resumes & cover letters (72)
South America (513)
Southern California (504)
Startups (1313)
Texas (151)
United States (5650)
Utah (39)
Vaccines (155)
Washington State (166)
Weight loss (44)
Date
Today (10)
Last 7 days (345)
Last 30 days (1413)
Last 365 days (24102)
2024 (16755)
2023 (26922)
2022 (30893)
2021 (34999)
2020 (37345)
2019 (37142)
2018 (27040)
2017 (19876)
2016 (19677)
2015 (23175)
2014 (12764)
2013 (9617)
2012 (10164)
2011 (10407)
2010 (9421)
370,271 Results for "30".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Singular Genomics Announces 1-for-30 Reverse Stock Split
Singular Genomics Systems, Inc. announced that on June 26, 2024, effective at 12:01 a.m. Eastern Time, it will effectuate a 1-for-30 reverse split of its common stock.
June 21, 2024
·
5 min read
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024
Scilex Holding Company provided certain preliminary unaudited financial results for the month ended June 30, 2024 and quarter ended June 30, 2024.
July 1, 2024
·
8 min read
Press Releases
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
July 1, 2024
·
1 min read
Business
Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30
Merck, known as MSD outside of the United States and Canada, will hold its second-quarter 2024 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Tuesday, July 30.
July 1, 2024
·
3 min read
Press Releases
FDA Roundup: August 30, 2024
September 2, 2024
·
3 min read
Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference
Satellos Bioscience Inc. today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical and scientific community during a panel discussion at PPMD’s 30th Annual Conference being held from June 27–29, 2024 in Orlando, Florida.
June 27, 2024
·
7 min read
Business
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Pharma-Bio Serv, Inc. announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and $4.8, million, respectively, a decrease of approximately $2.2 and $4.0 million when compared to the same periods last year.
June 14, 2024
·
2 min read
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Adcytherix SAS announced its incorporation and seed funding of € 30 million to develop novel antibody-drug- conjugates for the treatment of high unmet need diseases such as cancer.
June 11, 2024
·
2 min read
Deals
Fabric Acquires MeMD, Expanding Virtual Care Services to 30,000 Employers and 5 Million Members
Fabric, a leading healthcare technology company and care enablement system, announced the acquisition of MeMD from Walmart Inc. MeMD is a leading provider of virtual behavioral, urgent, and primary care benefits for 30,000 corporate, institutional, and health plan partners and 5 million members.
June 28, 2024
·
3 min read
Deals
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
Emergent BioSolutions Inc. announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd., a leading international pharmaceutical services company, for a total value of approximately $30 million.
June 20, 2024
·
4 min read
1 of 37,028
Next
